 0000950142-11-001803.txt : 20111101 0000950142-11-001803.hdr.sgml : 20111101 20111101105336 accession number:		0000950142-11-001803 conformed submission type:	sc 13d public document count:		3 filed as of date:		20111101 date as of change:		20111101 group members:		aisling capital iii lp group members:		aisling capital partners iii llc group members:		aisling capital partners iii lp group members:		andrew schiff group members:		dennis purcell group members:		steve elms subject company:	 	company data:	 		company conformed name:			zeltiq aesthetics inc 		central index key:			0001415336 		standard industrial classification:	electromedical & electrotherapeutic apparatus [3845] 		irs number:				000000000 		state of incorporation:			de 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-86461 		film number:		111170073 	business address:	 		street 1:		4698 willow road 		street 2:		suite 100 		city:			pleasanton 		state:			ca 		zip:			94588-2710 		business phone:		(925) 474-2500 	mail address:	 		street 1:		4698 willow road 		street 2:		suite 100 		city:			pleasanton 		state:			ca 		zip:			94588-2710 filed by:		 	company data:	 		company conformed name:			aisling capital iii lp 		central index key:			0001444717 		irs number:				000000000 		state of incorporation:			de 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		888 seventh avenue, 30th fl 		city:			new york 		state:			ny 		zip:			10106 		business phone:		212-651-6380 	mail address:	 		street 1:		888 seventh avenue, 30th fl 		city:			new york 		state:			ny 		zip:			10106 sc 13d 1 eh1100765_13d-zeltiq.htm schedule 13d eh1100765_13d-zeltiq.htm &#160; united states securities and exchange commission washington, d.c. 20549 &#160; schedule 13d &#160; (rule 13d-102) &#160; information to be included in statements filed pursuant to rule 13d-1(a) and amendments thereto filed pursuant to rule 13d-2(a) (amendment no. ___)* zeltiq aesthetics, inc. (name of issuer) common stock, par value $0.001 per share (title of class of securities) 98933q108 (cusip number) lloyd appel aisling capital llc 888 seventh avenue, 30 th floor new york, ny 10106 (212) 651-6380 (name, address and telephone number of person authorized to receive notices and communications) october 24, 2011 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box &#168; . &#160; note :&#160;&#160;schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see &#167;240.13d-7 for other parties to whom copies are to be sent. &#160; *&#160;&#160;the remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. &#160; the information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of section 18 of the securities exchange act of 1934 (the &#8220;act&#8221;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;2 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; aisling capital iii, lp &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; delaware &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 4,172,742 8 shared voting power &#160; 0 9 sole dispositive power &#160; 4,172,742 10 shared dispositive power &#160; 0 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; pn &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;3 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; aisling capital partners iii, lp &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; delaware &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 4,172,742 8 shared voting power &#160; 0 9 sole dispositive power &#160; 4,172,742 10 shared dispositive power &#160; 0 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; pn &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;4 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; aisling capital partners iii llc &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; delaware &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 4,172,742 8 shared voting power &#160; 0 9 sole dispositive power &#160; 4,172,742 10 shared dispositive power &#160; 0 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; oo &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;5 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; steve elms &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; united states &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 0 8 shared voting power &#160; 4,172,742 9 sole dispositive power &#160; 0 10 shared dispositive power &#160; 4,172,742 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; in &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;6 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; dennis purcell &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; united states &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 0 8 shared voting power &#160; 4,172,742 9 sole dispositive power &#160; 0 10 shared dispositive power &#160; 4,172,742 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; in &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;7 of 14 &#160; &#160; 1 name of reporting person i.r.s. identification no. of above persons (entities only) &#160; andrew schiff &#160; 2 check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160; o (b)&#160; x 3 sec use only &#160; &#160; &#160; 4 source of funds (see instructions) &#160; oo &#160; 5 check box if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#160; &#160; o 6 citizenship or place of organization &#160; united states &#160; number of shares beneficially owned by each reporting person with 7 sole voting power &#160; 0 8 shared voting power &#160; 4,172,742 9 sole dispositive power &#160; 0 10 shared dispositive power &#160; 4,172,742 11 aggregate amount beneficially owned by each reporting person &#160; 4,172,742 &#160; 12 check box if the aggregate amount in row (11) excludes certain shares (see instructions) &#160; &#160; o 13 percent of class represented by amount in row (11) &#160; 12.7% (1) &#160; 14 type of reporting person (see instructions) &#160; in &#160; &#160; ___________________ &#160; (1) based on 32,758,082 shares of the issuer&#8217;s common stock issued and outstanding following the initial public offering of the issuer&#8217;s common stock.&#160;&#160;the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended, was declared effective by the commission on october 18, 2011. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;8 of 14 &#160; item 1.&#160;&#160;&#160; security and issuer . &#160; the security to which this statement relates is common stock, par value $0.001 per share (the &#8220;common stock&#8221;).&#160;&#160;the principal executive offices of zeltiq aesthetics, inc. (the &#8220;issuer&#8221;) are located at 4698 willow road, suite 100, pleasanton, ca 94588. &#160; item 2.&#160;&#160; identity and background . &#160; (a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this schedule 13d is being filed on behalf of the following persons (each, a &#8220;reporting person&#8221; and collectively, the &#8220;reporting persons&#8221;): &#160; &#160; &#160;(i) aisling capital iii, lp (&#8220;aisling&#8221;); &#160; &#160; &#160;(ii) aisling capital partners iii, lp (&#8220;aisling partners&#8221;), the general partner of aisling; &#160; &#160; &#160;(iii) aisling capital partners iii llc (&#8220;aisling partners gp&#8221;) the general partner of aisling partners; &#160; &#160; &#160;(iv) mr. dennis purcell, the managing member of aisling partners gp; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;(v) mr. steve elms, the managing member of aisling partners gp; and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;(vi) mr. andrew schiff, the managing member of aisling partners gp. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the principal business address for each of the reporting persons is 888 seventh avenue, 30 th floor, new york, new york 10106. &#160; (c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;aisling was formed in order to engage in the acquiring, holding and disposing of investments in various companies.&#160;&#160;aisling partners is the general partner of aisling and was formed to act as the general partner of aisling, to make investments through aisling and to fulfill such other purposes as may be determined by aisling from time to time.&#160;&#160;aisling partners gp is the general partner of aisling partners and was formed to act as the general partner of aisling partners.&#160;&#160;dennis purcell, steve elms and andrew schiff are the managing members of aisling partners gp, who may be deemed to share the power to direct the voting and disposition of the common stock beneficially owned by the reporting persons.&#160;&#160;accordingly, pursuant to the regulations promulgated under section 13(d) of the securities exchange act of 1934, as amended, aisling partners, aisling gp, mr. elms, mr. purcell and mr. schiff each may be deemed to be a beneficial owner of the common stock held for the account of aisling. &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;9 of 14 &#160; (d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;none of the reporting persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). &#160; (e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;none of the reporting persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding were or are subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. &#160; (f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each of aisling and aisling partners is a delaware limited partnership.&#160;&#160;aisling partners gp is a delaware limited liability company.&#160;&#160;&#160;each of steve elms, dennis purcell and andrew schiff is a united states citizen. &#160; item 3.&#160;&#160;&#160; source and amount of funds or other consideration . &#160; as of the date hereof, each of the reporting persons may be deemed to beneficially own 4,172,742 shares of common stock, consisting of (i) 3,403,511 shares of common stock, issued upon the automatic conversion of 12,491,122 shares of series d convertible preferred stock of the issuer (&#8220;series d preferred stock&#8221;) held by aisling on october 18, 2011, prior to the effectiveness of the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the securities and exchange commission (the &#8220;commission&#8221;) on july 13, 2011, as amended (the &#8220;registration statement&#8221;), and declared effective by the commission on october 18, 2011 (the &#8220;effective date&#8221;)&#160;relating to the issuer&#8217;s initial public offering of common stock (the &#8220;initial public offering&#8221;) and (ii) 769,231 shares of common stock that were acquired by aisling on october 24, 2011 in the initial public offering with an aggregate purchase price of $10,000,003 at an initial public offering price of $13 per share (the &#8220;purchase&#8221;).&#160;&#160;the source of the purchase price for the purchase was capital contributions from the partners of aisling.&#160;&#160;no borrowed funds were used in the purchase. &#160; item 4.&#160;&#160;&#160; purpose of transaction . &#160; each reporting person expects to evaluate on an ongoing basis the issuer&#8217;s financial condition and prospects and its interest in, and intentions with respect to, the issuer and their investment in the securities of the issuer, which review may be based on various factors, including the issuer&#8217;s business and financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the issuer&#8217;s securities in particular, as well as other developments and other investment opportunities, which, if effected, could result in, among other things, &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;10 of 14 &#160; &#160; &#160; any of the matters identified in items 4(a)&#8722;(j) of schedule 13d.&#160;&#160;accordingly, each reporting person reserves the right to change its intentions and develop plans or proposals at any time, as it deems appropriate.&#160;&#160;in particular, each reporting person may at any time and from time to time, (i) in the open market, in privately negotiated transactions or otherwise, acquire additional common stock or other securities of the issuer, including acquisitions from affiliates of the reporting persons; (ii) dispose or transfer of all or a portion of the securities of the issuer, including the common stock, that the reporting persons now own or may hereafter acquire to any person or entity, including dispositions to affiliates of the reporting persons; (iii) enter into derivative transactions with institutional counterparties with respect to the issuer&#8217;s securities; (iv) cause or seek to cause the issuer or any of its subsidiaries to acquire all or a portion of another person's assets or business, including acquisitions from affiliates of the reporting persons; (v) cause or seek to cause the issuer or any of its subsidiaries to enter into one or more acquisitions, business combinations or mergers or to sell, transfer or otherwise dispose of all or any portion of its assets or business to any person or entity, including acquisitions, business combinations, mergers, sales, transfers and other dispositions with or to affiliates of the reporting persons; (vi) restructure the issuer&#8217;s or any of its subsidiaries&#8217; capitalization, indebtedness or holding company arrangements; (vii) make personnel changes to the present management of the issuer deemed necessary or desirable; (viii) change the identity of the directors of the issuer; (ix) make or propose any other material change in the issuer&#8217;s or any of its subsidiaries&#8217; corporate structure or business; or (x) engage in communications with one or more stockholders, officers or directors of the issuer and other persons regarding any of the matters described in clauses (i) through (ix) above. &#160; item 5.&#160;&#160;&#160; interest in securities of the issuer . &#160; (a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the aggregate percentage of shares of common stock reported as owned by each reporting person is based on 32,758,082 shares of common stock issued and outstanding following the initial public offering as stated in the registration statement .&#160;&#160; based on calculations made in accordance with rule 13d-3(d), each reporting person may be deemed to beneficially own 4,172,742 shares of common stock, constituting approximately 12.7% of the outstanding shares of common stock. &#160; (b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;each of aisling, aisling partners and aisling partners gp may be deemed to have sole power to direct the voting and disposition of the 4,172,742 shares of common stock that may be deemed to be beneficially owned by the reporting persons . &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;11 of 14 &#160; (ii)&#160;&#160;by virtue of the relationships between and among the reporting persons described in item 2 of this schedule 13d, each of the messrs. elms, purcell and schiff may be deemed to share the power to direct the voting and disposition of the 4,172,742 shares of common stock that may be deemed to be beneficially owned by the reporting persons. &#160; (c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;on october 18, 2011, prior to the effectiveness of the registration statement, 12,491,122 shares of series d preferred stock held by aisling were automatically converted into 3,403,511 shares of common stock.&#160;&#160;on october 24, 2011, aisling acquired 769,231 shares of common stock in the initial public offering with an aggregate purchase price of $10,000,003 at an initial public offering price of $13 per share.&#160;&#160;as a result, as of the date hereof, in the aggregate, each reporting person may be deemed to beneficially own 4,172,742 shares of common stock, constituting approximately 12.7% of the outstanding shares of common stock. &#160; (d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the partners of aisling have the right to participate in the receipt of dividends from, or proceeds from the sale of, the shares of common stock held for the account of aisling in accordance with their ownership interests in aisling. &#160; (e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;not applicable. &#160; item 6.&#160;&#160;&#160; contracts, arrangements, understandings or relationships with respect to securities of the issuer . &#160; pursuant to the third amended and restated investor rights agreement in connection with series d preferred stock (the &#8220;registration rights agreement&#8221;), dated may 26, 2010, by and among the issuer and the purchasers of series d preferred stock listed in exhibit a thereto, including aisling (the &#8220;holders&#8221;), aisling is entitled to require the issuer to register under the securities act of 1933, as amended (the &#8220;securities act&#8221;), 4,172,742 shares of common stock held by it.&#160;&#160;pursuant to the registration rights agreement, each holder may (i) upon a written request to the issuer, require the issuer to register its shares on form s-3 if the issuer is eligible to file a registration statement on form s-3 and if the aggregate price to the public of the shares offered is at least $1.0 million, unless the issuer has previously effected any registration of its common stock in the 12-month period preceding such request or (ii) require the issuer to include or &#8220;piggy-back&#8221; its shares if the issuer determines to register any of its common stock under the securities act either for its own account or for the account of other security holders.&#160;&#160;in addition, the registration rights agreement provides demand registration rights to a holder or holders of at least a &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;12 of 14 &#160; &#160; majority of registrable securities (as defined under the registration rights agreement), who may request the issuer to register all or portion of such holder&#8217;s shares on not more than two occasions if such request of registration covers a number of shares with an anticipated aggregate offering price, net of underwriting discounts and commissions, of at least $5.0 million.&#160;&#160;the issuer will pay any registration expenses relating to the registration rights of the holders.&#160;&#160;in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares the holders may include in the offering.&#160;&#160;the registration rights described above will expire upon the earlier of (i) five years after the closing of the initial public offering, (ii) when no holder holds registrable securities or (iii) upon consummation of certain events, including the sale of all of the issuer&#8217;s assets or a change of control of the issuer in which the issuer&#8217;s stockholders receive cash or marketable securities. &#160; on october 6, 2011, in connection with the initial public offering, aisling entered into a lock-up agreement (the &#8220;lock-up agreement&#8221;) with j.p. morgan securities llc and goldman, sachs &amp; co., as representatives of underwriters in the initial public offering. &#160;aisling has agreed that without prior written consent of j.p. morgan securities llc and goldman, sachs &amp; co., it will not offer, sell, contract to sell, pledge, grant any option to sell, or otherwise dispose of, directly or indirectly, any common stock during the 180-day period following the effective date, subject to certain exceptions, including: (i) the acquisition of any common stock pursuant to the underwriting agreement in the initial public offering, (ii) transfers of shares of common stock as gift, to any trust for the benefit of aisling or by will, (iii) distributions of common stock to members, limited partners or stockholders of aisling, (iv) transfers of common stock to aisling&#8217;s affiliates or to any investment fund or other entity controlled or managed by aisling and (v) acquisitions by aisling in the open market after the initial public offering or as part of a directed share program in the initial public offering (other than as provided below).&#160;&#160;with respect to (ii), (iii) and (iv), the transferee must provide a lock-up letter to j.p. morgan securities llc and goldman, sachs &amp; co. for the balance of the 180-day restricted period. with respect to (ii), (iii), (iv) and (v), no filing under the exchange act shall be made other than a filing on form 5 made after the 180-day restricted period.&#160;&#160;furthermore, pursuant to the lock-up agreement, notwithstanding the foregoing, with respect to shares of common stock acquired in the initial public offering, aisling has agreed that 96% of such shares are subject to the forgoing restrictions during the 45-day period following the effective date and 4% of such shares are subject to the foregoing restrictions during the 180-day period following the effective date.&#160;&#160;such 180-day &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;13 of 14 &#160; &#160; or 45-day restricted period will be automatically extended if (i) during the last 17 days of the 180-day or 45-day restricted period, the issuer issues an earnings release or material news or a material event relating to the issuer occurs or (ii) prior to the expiration of the 180-day or 45-day restricted period, the issuer announces that it will release earnings results during the 16-day period beginning on the last day of the 180-day or 45-day restricted period, in either of which case the restrictions described above will continue to apply until the expiration of the date that is 18 days after the issuance of the earnings release or the occurrence of the material news or material event.&#160;&#160;j.p. morgan securities llc and goldman, sachs &amp; co. may, in their sole discretion, permit early release of shares subject to the terms of the lock-up agreement. &#160; from time to time, each of the reporting persons may lend portfolio securities to brokers, banks or other financial institutions.&#160;&#160;these loans typically obligate the borrower to return the securities, or an equal amount of securities of the same class, to the lender and typically provide that the borrower is entitled to exercise voting rights and to retain dividends during the term of the loan.&#160;&#160;from time to time, to the extent permitted by applicable laws, each of the reporting persons may borrow securities, including the common stock, for the purpose of effecting, and may effect, short sale transactions, and may purchase securities for the purpose of closing out short positions in such securities. &#160; on november 1, 2011, each of the reporting persons entered into an agreement (the &#8220;joint filing agreement&#8221;) in which the parties agreed to the joint filing on behalf of each of them of statements on schedule 13d with respect to the securities of the issuer to the extent required by applicable law.&#160;&#160;the joint filing agreement is attached as an exhibit hereto and is incorporated herein by reference. &#160; item 7.&#160;&#160;&#160; materials to be filed as exhibits . &#160; &#160; exhibit 1: third amended and restated investor rights agreement, dated as of may 26, 2011, by and among the issuer and purchasers listed on exhibit a thereto, incorporated herein by reference to exhibit 10.23 to the issuer&#8217;s registration statement on form s-1 (file no. 333-175514), filed with the commission on july 13, 2011. &#160; &#160; exhibit 2: lock-up agreement, dated as of october 6, 2011, by and among aisling&#160;and j.p. morgan securities llc and goldman, sachs &amp; co., as representatives of several underwriters listed in schedule 1 to the underwriting agreement referred to therein. &#160; &#160; exhibit 3: joint filing agreement dated as of november 1, 2011, as required by rule 13d-1(k)(1) under the securities exchange act of 1934, as amended. &#160; &#160; &#160; &#160; &#160; &#160; cusip no. 98933q108 &#160; schedule 13d page&#160;&#160;14 of 14 &#160; &#160; &#160; signature &#160; after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. &#160; date:&#160;&#160;&#160;&#160;&#160;&#160;november 1, 2011 &#160; &#160; &#160; aisling capital iii, lp &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii, lp general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii llc general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; aisling capital partners iii, lp &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii llc general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; aisling capital partners iii llc &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: &#160; /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ steve elms &#160; &#160; &#160; steve elms &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ dennis purcell &#160; &#160; &#160; dennis purcell &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ andrew schiff &#160; &#160; &#160; andrew schiff &#160; &#160; &#160; &#160; &#160; &#160; attention.&#160;&#160;intentional&#160;&#160;misstatements&#160;&#160;or omissions of fact constitute federal criminal violations (see&#160;18&#160;u.s.c. 1001). &#160; &#160; &#160; ex-99 2 eh1100765_ex2.htm exhibit 2 eh1100765_ex2.htm exhibit 2 &#160; lock-up agreement &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;&#160;&#160; &#160;october 6, 2011 j.p. morgan securities llc goldman, sachs &amp; co. as representatives of the several underwriters listed in schedule i to the underwriting agreement referred to below c/o j.p. morgan securities llc 383 madison avenue new york, ny 10179 c/o goldman, sachs &amp; co. 200 west street new york, ny 10282 re:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;zeltiq aesthetics, inc. --- initial public offering ladies and gentlemen: the undersigned understands that you, as representatives of the several underwriters, propose to enter into an underwriting agreement (the "underwriting agreement") with zeltiq aesthetics, inc., a delaware corporation (the "company"), providing for the public offering (the "public offering") by the several underwriters named in schedule i to the underwriting agreement (the "underwriters"), of the company' s shares of common stock, $0.001 per share par value, (the "common stock"). capitalized terms used herein and not otherwise defined shall have the meanings set forth in the underwriting agreement. in consideration of the underwriters' agreement to purchase and make the public offering of common stock, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of j.p. morgan securities llc and goldman, sachs &amp; co. on behalf of the underwriters, the undersigned will not, during the period starting on the date hereof and ending 180 days after the date of the prospectus relating to the public offering (the "prospectus"), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock (including without limitation, common stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the securities and exchange commission and securities &#160; &#160; &#160; &#160; &#160; &#160; which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the common stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of common stock or such other securities, in cash or otherwise or (3) make any demand for or exercise any right with respect to the registration of any shares of common stock or any security convertible into or exercisable or exchangeable for common stock, in each case other than (a) any common stock to be sold by the undersigned pursuant to the underwriting agreement, (b) transfers of shares of common stock (i) as a bona fide gift or gifts, (ii) to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned or (iii) by will or intestacy to the undersigned's legal representative, heir or legatee, (c) distributions of shares of common stock to members, limited partners or stockholders of the undersigned, (d) transfers of shares of common stock to the undersigned's affiliates or to any investment fund or other entity controlled or managed by the undersigned, and (e) common stock acquired by the undersigned in open market transactions after the public offering or, other than as provided below, acquired by the undersigned in the public offering as part of a directed share program; provided that in the case of any transfer or distribution pursuant to clause (8), (c) or (d), each donee, distributee or transferee shall execute and deliver to the representatives a lock-up letter for the balance of the lock-up period in the form of this paragraph; and provided , further , that in the case of any transfer or distribution pursuant to clause (b), (c), (d) or (e), no filing by any party (donor, donee, transferor or transferee) under the securities exchange act of 1934, as amended, or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a form 5 made after the expiration of the l80-day period referred to above). if the undersigned is an officer or director of the company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any securities the undersigned may purchase in the public offering as part of a directed share program. &#160; notwithstanding the foregoing, 96% of any shares of common stock purchased by the undersigned in the public offering shall be subject to the restrictions set forth in clauses (1), (2) and (3) of the foregoing paragraph and the exceptions and provisos related thereto, but only for the period starting on the date hereof and ending 45 days after the date of the prospectus. for the avoidance of doubt, the remaining 4% of any shares of common stock purchased by the undersigned in the public offering shall be subject to such restrictions, exceptions and provisos for the full l80-day period. no provision in this agreement shall be deemed to restrict or prohibit the exercise or exchange by the undersigned of any option or warrant to acquire shares of common stock, or any other security exchangeable or exercisable for, or convertible into, common stock, provided that the undersigned does not transfer the common stock acquired on such exercise or exchange during the lock-up period, unless otherwise permitted pursuant to the terms of this agreement, and provided that the security to be exercised or exchange to acquire shares of common stock was not issued under a company stock plan not described in the prospectus and not in existence on the date of the underwriting agreement. in addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of a so-called "10b5-1 plan" at any time (other than the entry into or modification of such a plan in such a manner as to cause the sale of any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock within the lock-up period). &#160; &#160; &#160; 2 &#160; &#160; in the event that any shares of common stock are released from the lockup restrictions hereof, the same percentage of shares of the company's common stock held by the undersigned as were held by those of the person whose shares were released shall be immediately and fully released from any remaining lockup restrictions concurrently therewith; provided, however, that (a) j.p. morgan securities llc and goldman, sachs &amp; co. will not be obligated to release the undersigned from such lockup (i) unless and until j.p. morgan securities llc and goldman, sachs &amp; co. has first released more than 25,000 shares of common stock from such person's lockup agreement or (ii) if, with respect to any lock up release effected in order to permit a person otherwise subject to lockup restrictions hereunder to participate in an underwritten public offering, the undersigned has been given the opportunity to participate in such underwritten public offering on a pro rata basis and the undersigned declined to so participate, and (b) in the event that any percentage of such shares released from the lockup restrictions are subject to any restrictions, the same restrictions shall be applicable to the release of the same percentage of the company's shares held by the undersigned. in the event that the undersigned is released from any of its obligations under this agreement or, by virtue of this agreement, becomes entitled to offer, pledge, sell, contract to sell, or otherwise dispose of any shares of common stock (or any securities convertible into shares of common stock) prior to the date that is 180 days after the date of the prospectus, j.p. morgan securities llc and goldman, sachs &amp; co. shall use their commercially reasonable efforts to notify the undersigned within three (3) business days; provided that the failure to give such notice shall not give rise to any claim or liability against j.p. morgan securities llc, goldman, sachs &amp; co. or the underwriters. if the undersigned is an officer or director of the company, (i) j.p. morgan securities llc and goldman, sachs &amp; co. on behalf of the underwriters agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of common stock, j.p. morgan securities llc and goldman, sachs &amp; co. on behalf of the underwriters will notify the company of the impending release or waiver, and (ii) the company has agreed in the underwriting agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver. any release or waiver granted by j.p. morgan securities llc and goldman, sachs &amp; co. on behalf of the underwriters hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. the provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer. notwithstanding the foregoing, if (1) during the last 17 days of the 180-day or 45-day restricted period, as applicable, the company issues an earnings release or material news or a material event relating to the company occurs; or (2) prior to the expiration of the 180-day or 45-day restricted period, as applicable, the company announces that it will release earnings results during the 16-day period beginning on the last day of the 180-day period or 45-day period, as applicable, the restrictions imposed by this letter agreement shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event, unless j.p. morgan securities llc and goldman, sachs &amp; co. on behalf of the underwriters waive, in writing, such extension. &#160; &#160; &#160; 3 &#160; &#160; in furtherance of the foregoing, the company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this letter agreement. this letter agreement supersedes in all respects the letter agreement dated july __, 2011 between aisling capital iii, l.p. and the underwriters. the undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this letter agreement. all authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. the undersigned understands that, if (i) the underwriting agreement does not become effective, (ii) the underwriting agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the common stock to be sold thereunder, (iii) the company makes a public announcement that it will not be proceeding with the public offering, or (iv) a closing for the public offering has not yet occurred as of december 31, 2011, the undersigned shall be released from all obligations under this letter agreement. the undersigned understands that the underwriters are entering into the underwriting agreement and proceeding with the public offering in reliance upon this letter agreement. this letter agreement and any claim, controversy or dispute arising under or related to this letter agreement shall be governed by and construed in accordance with the laws of the state of new york, without regard to the conflict of laws principles thereof. [signature page follows] &#160; &#160; &#160; 4 &#160; &#160; &#160; very truly yours, &#160; &#160; &#160; &#160; &#160; aisling capital iii, l.p. &#160; &#160; &#160; &#160; &#160; &#160; by: /s/&#160;lloyd appel &#160; &#160; &#160; name:&#160; lloyd appel &#160; &#160; &#160; title:&#160;&#160;&#160; chief financial officer &#160; &#160; &#160; &#160; &#160; acknowledged as to this letter agreement superseding the letter agreement dated ____________, 2011 between aisling capital, iii l.p. and the underwriters: j.p. morgan securities llc &#160; &#160; by:&#160;&#160; authorized signatory &#160; goldman, sachs &amp; co. &#160; &#160; by:&#160;&#160; goldman, sachs &amp; co. &#160; [signature page to preferred lock-up] ex-99 3 eh1100765_ex3.htm exhibit 3 eh1100765_ex3.htm exhibit 3 &#160; joint filing agreement &#160; each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of rule 13d-1(k)(1) promulgated under the securities exchange act of 1934, as amended, that the schedule 13d to which this agreement is attached as an exhibit, and any amendments thereto, will be filed with the securities and exchange commission jointly on behalf of the undersigned.&#160;&#160;this agreement may be executed in one or more counterparts. &#160; date:&#160;&#160;&#160;&#160;&#160;&#160;november 1, 2011 &#160; &#160; &#160; aisling capital iii, lp &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii, lp general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii llc general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; aisling capital partners iii, lp &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: aisling capital partners iii llc general partner &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; aisling capital partners iii llc &#160; &#160; &#160; &#160; &#160; &#160; &#160; by: &#160; /s/ dennis purcell &#160; &#160; &#160; &#160; name:&#160; dennis purcell &#160; &#160; &#160; &#160; title:&#160;&#160;&#160;&#160; managing member &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ steve elms &#160; &#160; &#160; steve elms &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ dennis purcell &#160; &#160; &#160; dennis purcell &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; /s/ andrew schiff &#160; &#160; &#160; andrew schiff &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; 